{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T20:58:39Z","timestamp":1792789119002,"version":"4.5.0"},"reference-count":58,"publisher":"MDPI AG","issue":"19","license":[{"start":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T00:00:00Z","timestamp":1790640000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"University of Medicine and Pharmacy of Craiova","id":[{"id":"https:\/\/ror.org\/031d5vw30","id-type":"ROR","asserted-by":"crossref"}]},{"id":[{"id":"https:\/\/ror.org\/031d5vw30","id-type":"ROR","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Diagnostics"],"abstract":"<jats:p>Background\/Objectives: Systemic inflammation is a widely recognised feature of chronic obstructive pulmonary disease (COPD). The combined contribution of acute-phase reactants and pro-inflammatory cytokines to disease severity and exacerbation risk remains incompletely understood. This study evaluated the associations of TNF-\u03b1, IL-8, C-reactive protein (CRP), erythrocyte sedimentation rate (ESR), and fibrinogen with clinical outcomes in COPD and investigated whether a latent systemic inflammation construct provides additional information on exacerbation burden beyond individual biomarkers. Methods: We conducted a cross-sectional observational study in Romania, including 96 patients with clinically stable COPD. TNF-\u03b1 and IL-8 were measured by ELISA, whereas CRP, ESR, and fibrinogen were determined using standard laboratory methods. Spirometry and patient-reported outcomes were assessed, and exacerbation history over the preceding 12 months was recorded retrospectively via patient interviews and verified against medical records when available. Negative binomial regression, Cox proportional hazards modelling, and generalised structural equation modelling (GSEM) were used to examine associations between inflammatory biomarkers and clinical outcomes. Results: All five inflammatory biomarkers increased across GOLD grades and correlated inversely with spirometric indices, with ESR showing the strongest correlations. Higher biomarker concentrations were associated with worse CAT, mMRC, and SGRQ-C scores (all p &lt; 0.001). Individual biomarkers were associated with exacerbation frequency in unadjusted analyses but lost significance after adjustment for disease severity and comorbidities. In contrast, the latent systemic inflammation construct remained independently associated with annual exacerbation rate (IRR = 1.407, 95% CI: 1.145\u20131.668, p &lt; 0.001). Neither the individual biomarkers nor the eosinophilic phenotype showed a clinically meaningful association with time to first exacerbation. Conclusions: A latent systemic inflammation construct integrating multiple biomarkers remained independently associated with exacerbation burden after additional adjustment for GOLD spirometric grade, although the association was attenuated (IRR = 1.186 vs. 1.407 in the primary model) and should be interpreted as exploratory given the differing covariate adjustment sets. These findings support further investigation of integrated inflammatory profiling in COPD, particularly in prospective multicentre studies.<\/jats:p>","DOI":"10.3390\/diagnostics16193161","type":"journal-article","created":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T08:12:42Z","timestamp":1790669562000},"page":"3161","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Multidimensional Inflammatory Biomarker Profiling in COPD: A Latent Inflammatory Construct Associated with Disease Severity and Exacerbation Burden"],"prefix":"10.3390","volume":"16","author":[{"ORCID":"https:\/\/orcid.org\/0009-0000-9976-2256","authenticated-orcid":false,"given":"Oana Maria","family":"Catana","sequence":"first","affiliation":[{"name":"Doctoral School, University of Medicine and Pharmacy, 200349 Craiova, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0006-6335-1627","authenticated-orcid":false,"given":"Ramona","family":"Cioboata","sequence":"additional","affiliation":[{"name":"Pneumology Department, University of Medicine and Pharmacy, 200349 Craiova, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0006-5130-6757","authenticated-orcid":false,"given":"Denisa Maria","family":"Mitroi","sequence":"additional","affiliation":[{"name":"Doctoral School, University of Medicine and Pharmacy, 200349 Craiova, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3510-3838","authenticated-orcid":false,"given":"Ovidiu Mircea","family":"Zlatian","sequence":"additional","affiliation":[{"name":"Microbiology Department, University of Medicine and Pharmacy, 200349 Craiova, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mircea Popescu","family":"Driga","sequence":"additional","affiliation":[{"name":"Immunology Department, University of Medicine and Pharmacy, 200349 Craiova, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Costin Teodor","family":"Streba","sequence":"additional","affiliation":[{"name":"Pneumology Department, University of Medicine and Pharmacy, 200349 Craiova, Romania"},{"name":"Centre for Research in Gastroenterology and Hepatology (CCGH), 200349 Craiova, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2026,9,29]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1183\/09031936.03.00405703","article-title":"Systemic Effects of Chronic Obstructive Pulmonary Disease","volume":"21","author":"Noguera","year":"2003","journal-title":"Eur. Respir. J."},{"key":"ref_2","unstructured":"(2026, June 30). Global Initiative for Chronic Obstructive Lung Disease\u2013Global Initiative for Chronic Obstructive Lung Disease\u2013GOLD. Available online: https:\/\/goldcopd.org\/."},{"key":"ref_3","doi-asserted-by":"crossref","unstructured":"Wang, X., Gou, A., Wang, J., Li, J., and Gou, C. (2025). Global Trends and Future Projections of COPD Burden under Low-Temperature Risk: A 1990\u20132041 Analysis Based on GBD 2021. BMC Pulm. Med., 25.","DOI":"10.1186\/s12890-025-03811-w"},{"key":"ref_4","doi-asserted-by":"crossref","unstructured":"Xu, J., Zeng, Q., Li, S., Su, Q., and Fan, H. (2024). Inflammation Mechanism and Research Progress of COPD. Front. Immunol., 15.","DOI":"10.3389\/fimmu.2024.1404615"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1136\/thx.2009.130260","article-title":"Systemic Inflammation and Comorbidity in COPD: A Result of \u201coverspill\u201d of Inflammatory Mediators from the Lungs? Review of the Evidence","volume":"65","author":"Sinden","year":"2010","journal-title":"Thorax"},{"key":"ref_6","doi-asserted-by":"crossref","unstructured":"Agust\u00ed, A., Edwards, L.D., Rennard, S.I., MacNee, W., Tal-Singer, R., Miller, B.E., Vestbo, J., Lomas, D.A., Calverley, P.M.A., and Wouters, E. (2012). Persistent Systemic Inflammation Is Associated with Poor Clinical Outcomes in COPD: A Novel Phenotype. PLoS ONE, 7.","DOI":"10.1371\/journal.pone.0037483"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1136\/thorax.57.10.847","article-title":"Relationship between Exacerbation Frequency and Lung Function Decline in Chronic Obstructive Pulmonary Disease","volume":"57","author":"Donaldson","year":"2002","journal-title":"Thorax"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"1128","DOI":"10.1056\/NEJMoa0909883","article-title":"Susceptibility to Exacerbation in Chronic Obstructive Pulmonary Disease","volume":"363","author":"Hurst","year":"2010","journal-title":"N. Engl. J. Med."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"106091","DOI":"10.1016\/j.rmed.2020.106091","article-title":"Clinical and Spirometric Variables Are Better Predictors of COPD Exacerbations than Routine Blood Biomarkers","volume":"171","author":"Marras","year":"2020","journal-title":"Respir. Med."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.pharmthera.2017.06.008","article-title":"Anti-TNF\u03b1 Therapy in Inflammatory Lung Diseases","volume":"180","author":"Malaviya","year":"2017","journal-title":"Pharmacol. Ther."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"L566","DOI":"10.1152\/ajplung.00233.2002","article-title":"Pathophysiological Roles of Interleukin-8\/CXCL8 in Pulmonary Diseases","volume":"284","author":"Mukaida","year":"2003","journal-title":"Am. J. Physiol. Lung Cell. Mol. Physiol."},{"key":"ref_12","doi-asserted-by":"crossref","unstructured":"Ellingsen, J., Janson, C., Br\u00f6ms, K., H\u00e5rdstedt, M., H\u00f6gman, M., Lisspers, K., Palm, A., St\u00e4llberg, B., and Malinovschi, A. (2024). CRP, Fibrinogen, White Blood Cells, and Blood Cell Indices as Prognostic Biomarkers of Future COPD Exacerbation Frequency: The TIE Cohort Study. J. Clin. Med., 13.","DOI":"10.3390\/jcm13133855"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"1008","DOI":"10.1164\/ajrccm.164.6.2010067","article-title":"Elevated Plasma Fibrinogen Associated with Reduced Pulmonary Function and Increased Risk of Chronic Obstructive Pulmonary Disease","volume":"164","author":"Dahl","year":"2001","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1016\/j.archger.2010.10.015","article-title":"C-Reactive Protein (CRP) and Erythrocyte Sedimentation Rate (ESR) as Inflammation Markers in Elderly Patients with Stable Chronic Obstructive Pulmonary Disease (COPD)","volume":"53","author":"Corsonello","year":"2011","journal-title":"Arch. Gerontol. Geriatr."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1186\/1476-9255-7-29","article-title":"Smoking Status and Tumor Necrosis Factor-Alpha Mediated Systemic Inflammation in COPD Patients","volume":"7","author":"Tanni","year":"2010","journal-title":"J. Inflamm."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1186\/rr67","article-title":"Tumor Necrosis Factor-Alpha and Muscle Wasting: A Cellular Perspective","volume":"2","author":"Reid","year":"2001","journal-title":"Respir. Res."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1164\/rccm.200607-995OC","article-title":"The Safety and Efficacy of Infliximab in Moderate to Severe Chronic Obstructive Pulmonary Disease","volume":"175","author":"Rennard","year":"2007","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"ref_18","doi-asserted-by":"crossref","unstructured":"R\u00f6pcke, S., Holz, O., Lauer, G., M\u00fcller, M., Rittinghausen, S., Ernst, P., Lahu, G., Elmlinger, M., Krug, N., and Hohlfeld, J.M. (2012). Repeatability of and Relationship between Potential COPD Biomarkers in Bronchoalveolar Lavage, Bronchial Biopsies, Serum, and Induced Sputum. PLoS ONE, 7.","DOI":"10.1371\/journal.pone.0046207"},{"key":"ref_19","first-page":"13","article-title":"The Significance of Serum Interleukin-8 in Acute Exacerbations of Chronic Obstructive Pulmonary Disease","volume":"17","author":"Zhang","year":"2018","journal-title":"Tanaffos"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1164\/rccm.202301-0071OC","article-title":"Serum IL-8 as a Determinant of Response to Phosphodiesterase-4 Inhibition in Chronic Obstructive Pulmonary Disease","volume":"208","author":"Govoni","year":"2023","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"1681","DOI":"10.2147\/COPD.S412626","article-title":"Association Between IL-17 and Chronic Obstructive Pulmonary Disease: A Systematic Review and Meta-Analysis","volume":"18","author":"Ma","year":"2023","journal-title":"Int. J. Chronic Obstr. Pulm. Dis."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"2353","DOI":"10.1001\/jama.2013.5732","article-title":"Inflammatory Biomarkers and Exacerbations in Chronic Obstructive Pulmonary Disease","volume":"309","author":"Thomsen","year":"2013","journal-title":"JAMA"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1183\/09031936.00088209","article-title":"Systemic Inflammatory Markers in COPD: Results from the Bergen COPD Cohort Study","volume":"35","author":"Eagan","year":"2010","journal-title":"Eur. Respir. J."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"8569","DOI":"10.1038\/s41598-018-26766-x","article-title":"Are Systemic Manifestations Ascribable to COPD in Smokers? A Structural Equation Modeling Approach","volume":"8","author":"Boyer","year":"2018","journal-title":"Sci. Rep."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"1700698","DOI":"10.1183\/13993003.00698-2017","article-title":"ERS\/ATS Workshop Report on Respiratory Health Effects of Household Air Pollution","volume":"51","author":"Sood","year":"2018","journal-title":"Eur. Respir. J."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"291","DOI":"10.3109\/07853890.2012.732703","article-title":"Systemic Inflammatory Biomarkers and Co-Morbidities of Chronic Obstructive Pulmonary Disease","volume":"45","author":"Macnee","year":"2012","journal-title":"Ann. Med."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1183\/09031936.00128008","article-title":"Systemic Manifestations and Comorbidities of COPD","volume":"33","author":"Barnes","year":"2009","journal-title":"Eur. Respir. J."},{"key":"ref_28","doi-asserted-by":"crossref","unstructured":"Cioboata, R., Vlasceanu, S.G., Mitroi, D.M., Zlatian, O.M., Balteanu, M.A., Andrei, G.M., Biciusca, V., and Olteanu, M. (2025). History of Pulmonary Tuberculosis Accelerates Early Onset and Severity of COPD: Evidence from a Multicenter Study in Romania. J. Clin. Med., 14.","DOI":"10.3390\/jcm14175980"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1038\/nrc1252","article-title":"Cytokines in Cancer Pathogenesis and Cancer Therapy","volume":"4","author":"Dranoff","year":"2004","journal-title":"Nat. Rev. Cancer"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1056\/NEJMra1011170","article-title":"The Coagulopathy of Chronic Liver Disease","volume":"365","author":"Tripodi","year":"2011","journal-title":"N. Engl. J. Med."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1038\/sj.bjp.0706736","article-title":"How Corticosteroids Control Inflammation: Quintiles Prize Lecture 2005","volume":"148","author":"Barnes","year":"2006","journal-title":"Br. J. Pharmacol."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1136\/thx.54.7.581","article-title":"Usefulness of the Medical Research Council (MRC) Dyspnoea Scale as a Measure of Disability in Patients with Chronic Obstructive Pulmonary Disease","volume":"54","author":"Bestall","year":"1999","journal-title":"Thorax"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1183\/09031936.00102509","article-title":"Development and First Validation of the COPD Assessment Test","volume":"34","author":"Jones","year":"2009","journal-title":"Eur. Respir. J."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1378\/chest.06-0702","article-title":"Development and Validation of an Improved, COPD-Specific Version of the St. George Respiratory Questionnaire","volume":"132","author":"Meguro","year":"2007","journal-title":"Chest"},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"E70","DOI":"10.1164\/rccm.201908-1590ST","article-title":"Standardization of Spirometry 2019 Update. An Official American Thoracic Society and European Respiratory Society Technical Statement","volume":"200","author":"Graham","year":"2019","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"1324","DOI":"10.1183\/09031936.00080312","article-title":"multi-ethnic reference values for spirometry for the 3\u201395 year age range: The global lung function 2012 equations: Report of the Global Lung Function Initiative (GLI), ERS Task Force to Establish Improved Lung Function Reference Values","volume":"40","author":"Quanjer","year":"2012","journal-title":"Eur. Respir. J."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"1600791","DOI":"10.1183\/13993003.00791-2016","article-title":"Management of COPD Exacerbations: A European Respiratory Society\/American Thoracic Society Guideline","volume":"49","author":"Wedzicha","year":"2017","journal-title":"Eur. Respir. J."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1164\/rccm.201104-0597OC","article-title":"Acute Exacerbations of Chronic Obstructive Pulmonary Disease: Identification of Biologic Clusters and Their Biomarkers","volume":"184","author":"Bafadhel","year":"2011","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"2037","DOI":"10.1016\/j.jaci.2018.04.010","article-title":"Blood Eosinophil Count Thresholds and Exacerbations in Patients with Chronic Obstructive Pulmonary Disease","volume":"141","author":"Yun","year":"2018","journal-title":"J. Allergy Clin. Immunol."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1136\/bmj.2.5544.85","article-title":"Normal Erythrocyte Sedimentation Rate and Age","volume":"2","author":"Svedberg","year":"1967","journal-title":"Br. Med. J."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1186\/s12931-019-1268-7","article-title":"Blood Eosinophil Count, a Marker of Inhaled Corticosteroid Effectiveness in Preventing COPD Exacerbations in Post-Hoc RCT and Observational Studies: Systematic Review and Meta-Analysis","volume":"21","author":"Harries","year":"2020","journal-title":"Respir. Res."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"1601446","DOI":"10.1183\/13993003.01446-2016","article-title":"Phenotypes of COPD Patients with a Smoking History in Central and Eastern Europe: The POPE Study","volume":"49","author":"Koblizek","year":"2017","journal-title":"Eur. Respir. J."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/j.chest.2019.04.135","article-title":"Clinical Epidemiology of COPD: Insights From 10 Years of the COPDGene Study","volume":"156","author":"Maselli","year":"2019","journal-title":"Chest"},{"key":"ref_44","doi-asserted-by":"crossref","unstructured":"Cioboata, R., Balteanu, M.A., Mitroi, D.M., Vrabie, S.C., Vlasceanu, S.G., Andrei, G.M., Riza, A.L., Streata, I., Zlatian, O.M., and Olteanu, M. (2025). Beyond Smoking: Emerging Drivers of COPD and Their Clinical Implications in Low- and Middle-Income Countries: A Narrative Review. J. Clin. Med., 14.","DOI":"10.3390\/jcm14134633"},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1080\/15412555.2017.1383978","article-title":"Obesity in COPD: Revealed and Unrevealed Issues","volume":"14","author":"Zewari","year":"2017","journal-title":"COPD"},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"513948","DOI":"10.1155\/2010\/513948","article-title":"Release of Inflammatory Mediators by Human Adipose Tissue Is Enhanced in Obesity and Primarily by the Nonfat Cells: A Review","volume":"2010","author":"Fain","year":"2010","journal-title":"Mediat. Inflamm."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1136\/thx.2003.019588","article-title":"Association between Chronic Obstructive Pulmonary Disease and Systemic Inflammation: A Systematic Review and a Meta-Analysis","volume":"59","author":"Gan","year":"2004","journal-title":"Thorax"},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1016\/S0140-6736(04)16900-6","article-title":"Pathophysiology of Airflow Limitation in Chronic Obstructive Pulmonary Disease","volume":"364","author":"Hogg","year":"2004","journal-title":"Lancet"},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"1567","DOI":"10.1056\/NEJMoa1106955","article-title":"Small-Airway Obstruction and Emphysema in Chronic Obstructive Pulmonary Disease","volume":"365","author":"McDonough","year":"2011","journal-title":"N. Engl. J. Med."},{"key":"ref_50","doi-asserted-by":"crossref","unstructured":"Jones, P.W., Tabberer, M., and Chen, W.H. (2011). Creating Scenarios of the Impact of Copd and Their Relationship to Copd Assessment Test (CATTM) Scores. BMC Pulm. Med., 11.","DOI":"10.1186\/1471-2466-11-42"},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1164\/rccm.201209-1665OC","article-title":"Clusters of Comorbidities Based on Validated Objective Measurements and Systemic Inflammation in Patients with Chronic Obstructive Pulmonary Disease","volume":"187","author":"Vanfleteren","year":"2013","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"ref_52","doi-asserted-by":"crossref","unstructured":"Mariniello, D.F., D\u2019Agnano, V., Cennamo, D., Conte, S., Quarcio, G., Notizia, L., Pagliaro, R., Schiattarella, A., Salvi, R., and Bianco, A. (2024). Comorbidities in COPD: Current and Future Treatment Challenges. J. Clin. Med., 13.","DOI":"10.3390\/jcm13030743"},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1016\/S0140-6736(07)61383-X","article-title":"From COPD to Chronic Systemic Inflammatory Syndrome?","volume":"370","author":"Fabbri","year":"2007","journal-title":"Lancet"},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"1324","DOI":"10.1016\/j.jacc.2020.01.014","article-title":"Inflammation in Heart Failure: JACC State-of-the-Art Review","volume":"75","author":"Murphy","year":"2020","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1164\/rccm.200912-1869OC","article-title":"Outcomes in Patients with Chronic Obstructive Pulmonary Disease and Obstructive Sleep Apnea: The Overlap Syndrome","volume":"182","author":"Marin","year":"2010","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"e1020","DOI":"10.1016\/S2214-109X(25)00105-6","article-title":"Post-Pulmonary Tuberculosis Lung Function: A Systematic Review and Meta-Analysis","volume":"13","author":"Ratnakumar","year":"2025","journal-title":"Lancet Glob. Health"},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1016\/S2213-2600(17)30432-0","article-title":"Sputum or Blood Eosinophil Association with Clinical Measures of COPD Severity in the SPIROMICS Cohort","volume":"5","author":"Hastie","year":"2017","journal-title":"Lancet Respir. Med."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1164\/rccm.200508-1338PP","article-title":"Statistical Treatment of Exacerbations in Therapeutic Trials of Chronic Obstructive Pulmonary Disease","volume":"173","author":"Suissa","year":"2006","journal-title":"Am. J. Respir. Crit. Care Med."}],"container-title":["Diagnostics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2075-4418\/16\/19\/3161\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T08:32:52Z","timestamp":1790670772000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2075-4418\/16\/19\/3161"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,29]]},"references-count":58,"journal-issue":{"issue":"19","published-online":{"date-parts":[[2026,10]]}},"alternative-id":["diagnostics16193161"],"URL":"https:\/\/doi.org\/10.3390\/diagnostics16193161","relation":{},"ISSN":["2075-4418"],"issn-type":[{"value":"2075-4418","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,29]]}}}